HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition (Q40831269)

8

object named as

Rouas-Freiss N

1 reference

24 September 2017

2

Menier C

1 reference

24 September 2017

Riteau B

1

1 reference

24 September 2017

Khalil-Daher I

3

1 reference

24 September 2017

Martinozzi S

4

1 reference

24 September 2017

Pla M

A class I antigen, HLA-G, expressed in human trophoblasts

5

1 reference

24 September 2017

1 February 2001

1 reference

24 September 2017

International Immunology

1 reference

24 September 2017

13

1 reference

24 September 2017

193-201

1 reference

24 September 2017

2

1 reference

24 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Detection of soluble HLA-G molecules in plasma and amniotic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

HLA-G: a tolerance molecule from the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

The immunotolerance role of HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193

Implication of HLA-G molecule in heart-graft acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F13.2.193